Navigation Links
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
Date:5/24/2011

PALO ALTO, Calif. and AUCKLAND, New Zealand, May 24, 2011 /PRNewswire/ -- Centella Therapeutics, Inc., a subsidiary of Varian Medical Systems, Inc. (NYSE: VAR), and Auckland UniServices Ltd. of Auckland, New Zealand, today announced that they have entered into a licensing agreement granting Centella exclusive rights to CEN-209, a novel investigational drug designed to enhance the effectiveness of radiotherapy and chemotherapy when treating solid tumors that are hypoxic—or oxygen-starved—and therefore resistant to standard forms of radiotherapy and chemotherapy.

CEN-209 is selectively activated in areas of low oxygen often found within solid tumors.  These areas develop within tumors due to their rapid growth, which impairs the blood vessels bringing nutrients and oxygen, resulting in hypoxia.  

"Hypoxic tumors are generally resistant to radiotherapy and to chemotherapy, and there is no effective treatment for such tumors today," says Thorsten Melcher, PhD, President of Centella Therapeutics.  "Hypoxia occurs in most types of solid tumors, but not necessarily in every patient with a given tumor type. For example, in lung cancer patients, roughly 50 percent of tumors have hypoxic regions.(1)  In the future, successful treatment of hypoxic tumors will likely require identifying affected patients and giving them a hypoxia-specific drug, like CEN-209, in addition to standard treatment."(2)

Radiotherapy works by damaging tumor cells' DNA, but only in well-oxygenated areas, whereas CEN-209 is designed to 'switch on' and damage the DNA only of hypoxic cells, leaving other cells alone," Melcher adds.  "Thus, the two treatment approaches have the potential to complement each other, and CEN-209 is specifically designed to be preferentially used in combination with radiotherapy."

Professor William Wilson and Associate Profes
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 /PRNewswire-iReach/ -- Today leading web researchers Change Sciences ... Pharmaceutical web sites for usability, engagement, and conversion. The ... platform, which compares how people experience sites with competitors ... The top three performers are easier to use, ... bottom performers have usability problems, lack aspects of design ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- ... a new specialty pharmaceutical company dedicated to ... innovative injectable and sustained release drug therapies ... medical needs, today announced the acquisition of ... Technology®) platform and associated product pipeline. Acquisition ...
(Date:6/19/2013)... June 19, 2013  Omnicell, Inc. (NASDAQ: ... and supply management solutions and analytics software for ... the number one overall pharmacy equipment vendor in ... KLAS, a leading independent healthcare research firm, compared ... in its annual rankings. Omnicell also received the ...
Breaking Medicine Technology:Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 3Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 4
(Date:6/20/2013)... Michigan-based natural health and wellness ... David R Hamilton which revealed that performing random acts ... in the release of the feel-good hormone Oxytocin in ... known as the ‘cardio protective’ hormone because it temporarily ... heart health. , “Being kind is something we can ...
(Date:6/20/2013)... Norwalk, CT (PRWEB) June 20, 2013 ... looking to energize their sales or test new markets, ... the U.S. now have a new sales outsourcing ... and sustained sales revenue. , Strategy Sales ... sales professionals. Founded by business owners for business owners, ...
(Date:6/20/2013)... Omaha, NE (PRWEB) June 20, 2013 ... President’s Higher Education Community Service Honor Roll – the ... for its commitment to volunteering, student- service learning and ... The award, presented by the Corporation for National and ... is the sixth for Creighton. “Our foundation at Creighton ...
(Date:6/19/2013)... 20, 2013 With the winter season ... together their winter season Santiago day trips ... trips in and around Santiago this season, expert mountain ... Central Andes for backcountry skiing, challenging rock climbing adventures, ... have always dreamed of skiing in Chile , ...
(Date:6/19/2013)... Paleo Burn has finally been released after much ... body they desire with no fad diets, pills, or extreme ... food products, Ken Smith was bold enough to expose the ... automatic, and permanent solution for weight loss. , ... a quick review of Paleo Burn, TotalWellnessCleanse.net believes this guide ...
Breaking Medicine News(10 mins):Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 2Health News:Kindness Can Be Good for The Heart Says BioGirl Health Show 3Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 2Health News:Strategy Sales Partners Launches to Provide Sales Outsourcing Assistance to Businesses 3Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 2Health News:Creighton Again Named to President’s Honor Roll - University Picks Up Sixth Recognition Award for Service 3Health News:Chile Montaña Announces Winter Season Santiago Day Trips 2Health News:Chile Montaña Announces Winter Season Santiago Day Trips 3Health News:Paleo Burn Review Released by TotalWellnessCleanse.net 2
... Justice Department today announced that it has reached ... the conditions at Georgia,s seven psychiatric hospitals. The ... in 2007 and issued findings regarding Georgia Regional ... Department subsequently entered into negotiations regarding remedies the ...
... SHELBY TOWNSHIP, Mich., Jan. 15 Dr. Brett Kotlus ... radiofrequency energy and,tissue glue to lift the brow for ... to previous brow-lifting techniques. Cosmetic,surgeons are using multiple new ... Dr. Brett Kotlus, of Allure Medical Spa, ...
... February 3, 2009, legendary folk icon, Judy Collins, will ... to benefit The James E. Marshall OCD Foundation, an ... Disorder (OCD). Hosted by television and radio personality, ... The Union League Club in New York City and ...
... The need for full integration of ... health care system was the top priority of eight ... James H. Scully Jr., M.D., when they met Thursday ... transition team."It,s clear that the incoming administration is looking ...
... the White House changes guard next week, a new ... for Health Solutions identifies $530 billion in opportunities to ... over the next 10 years."Against the backdrop of a ... funds, transforming the health care system to address major ...
... Outbreaks of viral gastroenteritis, or "stomach flu," are sharply ... Health to offer tips to help prevent the spread ... cause of the illness."Norovirus infection is very common this ... Health Secretary Everette James. "If you have symptoms such ...
Cached Medicine News:Health News:Justice Department Reaches Settlement With Georgia Regarding State's Seven Psychiatric Hospitals 2Health News:Justice Department Reaches Settlement With Georgia Regarding State's Seven Psychiatric Hospitals 3Health News:Looking Years Younger, Raising a Few Brows 2Health News:Legendary Folk Icon, Judy Collins, to Perform at The Fifth Annual James E. Marshall OCD Foundation Beyond Beauty Gala 2Health News:Legendary Folk Icon, Judy Collins, to Perform at The Fifth Annual James E. Marshall OCD Foundation Beyond Beauty Gala 3Health News:Mental Health Leaders Meet with Transition Team 2Health News:As New Administration Takes Office, Deloitte Report Identifies $530 Billion Savings Opportunity for Health Care Reform Over Next 10 Years 2Health News:As New Administration Takes Office, Deloitte Report Identifies $530 Billion Savings Opportunity for Health Care Reform Over Next 10 Years 3Health News:As New Administration Takes Office, Deloitte Report Identifies $530 Billion Savings Opportunity for Health Care Reform Over Next 10 Years 4Health News:Pennsylvania Health Department Offers Tips to Prevent Spread of Highly Contagious Norovirus 2
... ORTHOSET Radiopaque Bone Cement consists ... a sterile,ampule containing bone cement ... and a sterile polyethylene bag,containing ... peelable pouch. The interiors of ...
A "doughy" type of bone cement intended for manual application....
... Videoscopes provide superior image quality and ... the camera head with a C-mount ... more light at the operative site ... image clarity and reliability.,The Videoscopes have ...
... OMEGA 180 features a wide range of ... and Variable Pupil Control (U.S. Patent #4,684,227). ... down to 1.2mm. Heine's unique Diffuser aperture ... learning BIO easier, and simplifying difficult examinations. ...
Medicine Products: